Interestingly, increase of HO-1 expression in MM cells treated with bortezomib is accompanied by upregulation of TLR4 [4], indicating a potential connection between these two signaling pathways that may synergistically work to resolve ER stress and maintain mitochondrial integrity. The gene discussed is TLR4; the disease is Miyoshi myopathy.